AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,813,000 | -91.5% | 356,492 | -84.8% | 7.66% | -75.9% |
| Q4 2019 | $56,811,000 | +25.8% | 2,350,477 | 0.0% | 31.84% | +84.6% |
| Q3 2019 | $45,176,000 | -21.6% | 2,350,477 | +20.5% | 17.25% | -8.7% |
| Q2 2019 | $57,637,000 | -37.8% | 1,950,477 | 0.0% | 18.90% | -21.6% |
| Q1 2019 | $92,648,000 | +31.6% | 1,950,477 | 0.0% | 24.12% | +4.3% |
| Q4 2018 | $70,412,000 | -33.0% | 1,950,477 | +14.2% | 23.13% | -0.3% |
| Q3 2018 | $105,130,000 | -8.9% | 1,708,046 | 0.0% | 23.20% | -6.6% |
| Q2 2018 | $115,379,000 | +9.0% | 1,708,046 | -12.4% | 24.85% | +7.7% |
| Q1 2018 | $105,813,000 | -9.2% | 1,950,477 | 0.0% | 23.06% | -29.5% |
| Q4 2017 | $116,541,000 | +22.9% | 1,950,477 | 0.0% | 32.70% | +25.3% |
| Q3 2017 | $94,793,000 | -7.5% | 1,950,477 | 0.0% | 26.11% | -22.0% |
| Q2 2017 | $102,498,000 | +41.6% | 1,950,477 | +22.2% | 33.48% | +20.5% |
| Q1 2017 | $72,410,000 | +19.7% | 1,596,701 | -0.1% | 27.79% | +5.7% |
| Q4 2016 | $60,501,000 | -5.6% | 1,598,452 | -5.9% | 26.29% | -12.2% |
| Q3 2016 | $64,078,000 | +170.6% | 1,697,884 | +26.2% | 29.95% | +84.3% |
| Q2 2016 | $23,678,000 | +103.4% | 1,345,313 | +40.6% | 16.25% | +80.4% |
| Q1 2016 | $11,639,000 | +105.3% | 957,126 | +311.2% | 9.00% | +79.1% |
| Q4 2015 | $5,668,000 | – | 232,757 | – | 5.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|